20 µg recombinant hepatitis B vaccine at months 0, 1, 2, and 6

BIOLOGICAL2 trials

Sponsors

Shanxi Medical University

Conditions

Hepatitis B Vaccine

Phase 4

Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients

Shanxi Medical UniversityHepatitis B Vaccine

Start: 2019-06-05End: 2023-12-31Target: 300Updated: 2019-05-24

Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Shanxi Medical UniversityHepatitis B Vaccine

Start: 2019-05-26End: 2023-12-31Target: 300Updated: 2019-05-24

Related Papers

Immunogenicity persistence after four intramuscular triple-dose or standard-dose hepatitis B vaccine in patients receiving methadone maintenance treatment: A 1-year follow-up study in China

Human Vaccines & Immunotherapeutics2025-01-17

Immunogenicity and safety of 4 intramuscular standard-dose and high-dose hepatitis B vaccine in people living with HIV: a randomized, parallel-controlled trial

Expert Review of Vaccines2022-03-214 citations

Immunogenicity, safety, and compliance of high- and standard-strength four-dose hepatitis B vaccination regimens in patients receiving methadone maintenance therapy in China: a randomized, parallel-arm controlled trial

Expert Review of Vaccines2021-09-103 citations